Works matching AU Othus, Megan

Results: 80
    1

    Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma.

    Published in:
    NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-024-00798-1
    By:
    • Patel, Sandip P.;
    • Cano-Linson, Eleanor;
    • Chae, Young Kwang;
    • Schokrpur, Shiruyeh;
    • Lao, Christopher D.;
    • Powers, Benjamin C.;
    • Victor, Adrienne I.;
    • Onitilo, Adedayo A.;
    • Shin, Sarah;
    • Takebe, Naoko;
    • Threlkel, Sara;
    • McLeod, Christine M.;
    • Chen, Helen X.;
    • Sharon, Elad;
    • Othus, Megan;
    • Ryan, Christopher W.;
    • Blanke, Charles D.;
    • Kurzrock, Razelle
    Publication type:
    Article
    2
    3

    AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report.

    Published in:
    Biomarker Research, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40364-020-00208-1
    By:
    • Pogosova-Agadjanyan, Era L.;
    • Moseley, Anna;
    • Othus, Megan;
    • Appelbaum, Frederick R.;
    • Chauncey, Thomas R.;
    • Chen, I-Ming L.;
    • Erba, Harry P.;
    • Godwin, John E.;
    • Jenkins, Isaac C.;
    • Fang, Min;
    • Huynh, Mike;
    • Kopecky, Kenneth J.;
    • List, Alan F.;
    • Naru, Jasmine;
    • Radich, Jerald P.;
    • Stevens, Emily;
    • Willborg, Brooke E.;
    • Willman, Cheryl L.;
    • Wood, Brent L.;
    • Zhang, Qing
    Publication type:
    Article
    4

    Seasonal Variation in the Diagnosis of Retinoblastoma.

    Published in:
    Ophthalmic Epidemiology, 2023, v. 30, n. 5, p. 509, doi. 10.1080/09286586.2022.2153872
    By:
    • Singh, Shonar;
    • Nishath, Thamanna;
    • Fabian, Ido Didi;
    • Li, Xiudi;
    • Othus, Megan;
    • Tzukikawa, Mai;
    • Stacey, Andrew W.
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Melanoma's deadly march to the brain.

    Published in:
    Cancer (0008543X), 2011, v. 117, n. 8, p. 1560, doi. 10.1002/cncr.25716
    By:
    • Othus, Megan;
    • Moon, James;
    • Margolin, Kim
    Publication type:
    Article
    17
    18

    Proteogenomic characterization of highly enriched viable leukemic blasts in acute myeloid leukemia: A SWOG report.

    Published in:
    EJHaem, 2024, v. 5, n. 6, p. 1243, doi. 10.1002/jha2.1041
    By:
    • Naru, Jasmine;
    • Othus, Megan;
    • Lin, ChenWei;
    • Biernacki, Melinda A.;
    • Bleakley, Marie;
    • Chauncey, Thomas R.;
    • Erba, Harry P.;
    • Fang, Min;
    • Fitzgibbon, Matthew P.;
    • Gafken, Phillip R.;
    • Ivey, Richard G.;
    • Kennedy, Jacob J.;
    • Lorentzen, Travis D.;
    • Meshinchi, Soheil;
    • Moseley, Anna;
    • Pogosova‐Agadjanyan, Era L.;
    • Liu, Vivian M.;
    • Radich, Jerald P.;
    • Voytovich, Uliana J.;
    • Wang, Pei
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25

    Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review.

    Published in:
    Cancers, 2023, v. 15, n. 9, p. 2561, doi. 10.3390/cancers15092561
    By:
    • Eljilany, Islam;
    • Noor, Arish;
    • Paravathaneni, Mahati;
    • Yassine, Ibrahim;
    • Lee, Sandra J.;
    • Othus, Megan;
    • Moon, James;
    • Kirkwood, John M.;
    • Sondak, Vernon K.;
    • Ribas, Antoni;
    • Grossmann, Kenneth F.;
    • Tarhini, Ahmad A.
    Publication type:
    Article
    26
    27

    Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms.

    Published in:
    Cancers, 2022, v. 14, n. 12, p. 2934, doi. 10.3390/cancers14122934
    By:
    • Godwin, Colin D.;
    • Rodríguez-Arbolí, Eduardo;
    • Othus, Megan;
    • Halpern, Anna B.;
    • Appelbaum, Jacob S.;
    • Percival, Mary-Elizabeth M.;
    • Hendrie, Paul C.;
    • Oehler, Vivian G.;
    • Keel, Siobán B.;
    • Abkowitz, Janis L.;
    • Cooper, Jason P.;
    • Cassaday, Ryan D.;
    • Estey, Elihu H.;
    • Walter, Roland B.
    Publication type:
    Article
    28

    Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.

    Published in:
    Cancers, 2020, v. 12, n. 9, p. 2339, doi. 10.3390/cancers12092339
    By:
    • Morsink, Linde M.;
    • Sandmaier, Brenda M.;
    • Othus, Megan;
    • Palmieri, Raffaele;
    • Granot, Noa;
    • Bezerra, Evandro D.;
    • Wood, Brent L.;
    • Mielcarek, Marco;
    • Schoch, Gary;
    • Davis, Chris;
    • Flowers, Mary E. D.;
    • Deeg, H. Joachim;
    • Appelbaum, Frederick R.;
    • Storb, Rainer;
    • Walter, Roland B.
    Publication type:
    Article
    29

    SWOG 1609 cohort 48: anti–CTLA‐4 and anti–PD‐1 for advanced gallbladder cancer.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 17, p. 2918, doi. 10.1002/cncr.35243
    By:
    • Patel, Sandip P.;
    • Guadarrama, Elizabeth;
    • Chae, Young Kwang;
    • Dennis, Michael J.;
    • Powers, Benjamin C.;
    • Liao, Chih‐Yi;
    • Ferri, William A.;
    • George, Thomas J.;
    • Sharon, Elad;
    • Ryan, Christopher W.;
    • Othus, Megan;
    • Lopez, Gabby;
    • Blanke, Charles D.;
    • Kurzrock, Razelle
    Publication type:
    Article
    30

    A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 10, p. 1784, doi. 10.1002/cncr.35200
    By:
    • Algazi, Alain P.;
    • Moon, James;
    • Lao, Christopher D.;
    • Chmielowski, Bartosz;
    • Kendra, Kari L.;
    • Lewis, Karl D.;
    • Gonzalez, Rene;
    • Kim, Kevin;
    • Godwin, John E.;
    • Curti, Brendan D.;
    • Latkovic-Taber, Michaella;
    • Lomeli, Shirley H.;
    • Gufford, Brandon T.;
    • Scumpia, Philip O.;
    • Lo, Roger S.;
    • Othus, Megan;
    • Ribas, Antoni
    Publication type:
    Article
    31
    32

    A phase II basket trial of Dual Anti–CTLA–4 and Anti–PD–1 Blockade in Rare Tumors (DART) SWOG S1609: High‐grade neuroendocrine neoplasm cohort.

    Published in:
    Cancer (0008543X), 2021, v. 127, n. 17, p. 3194, doi. 10.1002/cncr.33591
    By:
    • Patel, Sandip Pravin;
    • Mayerson, Edward;
    • Chae, Young Kwang;
    • Strosberg, Jonathan;
    • Wang, Jue;
    • Konda, Bhavana;
    • Hayward, Jourdain;
    • McLeod, Christine M.;
    • Chen, Helen X.;
    • Sharon, Elad;
    • Othus, Megan;
    • Ryan, Christopher W.;
    • Plets, Melissa;
    • Blanke, Charles D.;
    • Kurzrock, Razelle
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39

    Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy.

    Published in:
    British Journal of Haematology, 2014, v. 165, n. 4, p. 497, doi. 10.1111/bjh.12775
    By:
    • Coutre, Steven E.;
    • Othus, Megan;
    • Powell, Bayard;
    • Willman, Cheryl L.;
    • Stock, Wendy;
    • Paietta, Elisabeth;
    • Levitan, Denise;
    • Wetzler, Meir;
    • Attar, Eyal C.;
    • Altman, Jessica K.;
    • Gore, Steven D.;
    • Maher, Tracy;
    • Kopecky, Kenneth J.;
    • Tallman, Martin S.;
    • Larson, Richard A.;
    • Appelbaum, Frederick R.
    Publication type:
    Article
    40
    41
    42

    A model for prediction of FLT3- ITD and NPM1 (without FLT3- ITD) positivity in patients with newly diagnosed acute myeloid leukaemia.

    Published in:
    British Journal of Haematology, 2013, v. 163, n. 1, p. 130, doi. 10.1111/bjh.12450
    By:
    • Ostronoff, Fabiana;
    • Othus, Megan;
    • Kantarjian, Hagop M.;
    • Meshinchi, Soheil;
    • Ravandi, Farhad;
    • Hendrie, Paul C.;
    • Faderl, Stefan;
    • Becker, Pamela S.;
    • Cortes, Jorge E.;
    • Pagel, John M.;
    • Petersdorf, Stephen H.;
    • Godwin, John E.;
    • Willman, Cheryl L.;
    • Pierce, Sherry A.;
    • List, Alan F.;
    • Sandhu, Ravinder K.;
    • Walter, Roland B.;
    • Stirewalt, Derek L.;
    • Appelbaum, Frederick R.;
    • Estey, Elihu H.
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49

    Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes.

    Published in:
    Diabetes Care, 2022, v. 45, n. 5, p. 1170, doi. 10.2337/dc21-2213
    By:
    • Chen, Xuan;
    • Affinati, Alison H.;
    • Lee, Yungchun;
    • Turcu, Adina F.;
    • Henry, Norah Lynn;
    • Schiopu, Elena;
    • Qin, Angel;
    • Othus, Megan;
    • Clauw, Dan;
    • Ramnath, Nithya;
    • Zhao, Lili
    Publication type:
    Article
    50

    Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit.

    Published in:
    2020
    By:
    • Grossman, Douglas;
    • Okwundu, Nwanneka;
    • Bartlett, Edmund K.;
    • Marchetti, Michael A.;
    • Othus, Megan;
    • Coit, Daniel G.;
    • Hartman, Rebecca I.;
    • Leachman, Sancy A.;
    • Berry, Elizabeth G.;
    • Korde, Larissa;
    • Lee, Sandra J.;
    • Bar-Eli, Menashe;
    • Berwick, Marianne;
    • Bowles, Tawnya;
    • Buchbinder, Elizabeth I.;
    • Burton, Elizabeth M.;
    • Chu, Emily Y.;
    • Curiel-Lewandrowski, Clara;
    • Curtis, Julia A.;
    • Daud, Adil
    Publication type:
    journal article